Evogene Ltd. (EVGN)
NASDAQ: EVGN
· Real-Time Price · USD
1.34
-0.02 (-1.47%)
At close: Aug 15, 2025, 3:59 PM
1.38
2.60%
After-hours: Aug 15, 2025, 05:50 PM EDT
Evogene Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.99M | -5K | -8.22M | -5.99M | -3.85M | -6.6M | -3.86M | -7.78M | -6.98M | -3.82M | -7.16M | -9.75M | -9.11M | -8.08M | -8.34M | -6.9M | -7.12M |
Depreciation & Amortization | 579K | 593K | 627K | 613K | 671K | 663K | 661K | 647K | 641K | 641K | 645K | 613K | 681K | 552K | 548K | 574K | 560K |
Stock-Based Compensation | 316K | 317K | 479K | 460K | 539K | 113K | 545K | 801K | 418K | 291K | 65K | 419K | 411K | 737K | 783K | 558K | 531K |
Other Working Capital | -868K | -970.33K | 297K | -283.23K | -71K | 26.78K | -646K | 708K | -687K | 535K | 271K | 33K | -600K | -49K | -26K | 86K | -21K |
Other Non-Cash Items | -1.29M | -5.55M | 2.21M | 259K | -219K | -405.14K | -136K | 191K | 216K | 218K | -107K | 1.93M | 1.04M | -771K | -336K | -701K | 902K |
Deferred Income Tax | n/a | 7K | 1K | 1K | n/a | -4K | -5K | 21K | -45K | 45K | 5K | 38K | 2K | -6K | 8K | 3K | 8K |
Change in Working Capital | -1.8M | -572.33K | -25K | -803K | -1.92M | 572.83K | -1.52M | 1.03M | -493K | 369K | -501K | 92K | -731K | -633K | 1.53M | 329K | 430K |
Operating Cash Flow | -5.18M | -5.21M | -4.93M | -5.46M | -4.11M | -5.66M | -4.32M | -5.09M | -6.24M | -2.26M | -7.06M | -6.66M | -7.71M | -8.21M | -5.81M | -6.13M | -4.69M |
Capital Expenditures | -122K | -322K | -132K | -31K | -141K | -80.49K | -216K | -124K | -359K | -199K | -225K | -305K | -442K | -137K | -180K | -224K | -183K |
Cash Acquisitions | n/a | n/a | n/a | -81.95 | 10K | -92.66 | -401.86 | -417.81 | 26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -2.33M | -17.15M | n/a | 3.24M | -4.23M | -446.1K | 3.96M | -14.06M | -26K | -252K | 5.15K | -659K | n/a | -1.71M | -2.01M | -709K | -29.78M |
Sales Maturities Of Investments | n/a | 26.23M | 2.1M | n/a | n/a | -24.67K | 3.86M | 6.29M | 637K | 4K | 203K | 2.73M | 12.42M | 3.98M | 611K | 9.71M | 201K |
Other Investing Acitivies | 2K | n/a | 48K | 81.95 | n/a | -1.34 | -3.96M | 417.81 | 26K | n/a | -5.15K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -2.45M | 8.76M | 2.02M | 3.21M | -4.36M | -551.35K | 3.64M | -7.9M | 304K | -447K | -22K | 1.76M | 11.98M | 2.13M | -1.58M | 8.77M | -29.76M |
Debt Repayment | -143K | -206K | -233K | -231K | -231K | -212K | -211K | -207K | -206K | -437K | 10.13M | -369K | -123K | -143K | -121K | -149K | -167K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -16K | -18.73K | 4.93M | -3K | -139K | -40.05K | 348.73K | 10.42M | -9K | 7.14K | 42K | 10.74K | 23K | 570K | 414K | 272K | 548K |
Financial Cash Flow | -159K | 440K | 4.73M | -151K | -367K | -147K | 7.8M | 10.45M | 53K | -356K | 10.17M | -369K | -100K | -103K | 1.95M | 937K | 27.49M |
Net Cash Flow | -7.81M | 3.98M | 1.83M | -2.43M | -8.86M | -6.56M | 7.1M | -2.77M | -5.98M | -2.88M | 2.99M | -7.15M | 3.69M | -5.31M | -5.12M | 4.11M | -7.59M |
Free Cash Flow | -5.3M | -5.53M | -5.06M | -5.49M | -4.25M | -5.74M | -4.53M | -5.21M | -6.6M | -2.46M | -7.28M | -6.96M | -8.15M | -8.34M | -5.99M | -6.36M | -4.87M |